International Journal of Nanomedicine

Next-Generation Nanomedicine: From Tissue Engineering to Precision Cancer Treatment

The convergence of nanotechnology and materials science is ushering in a transformative era for healthcare, shifting the paradigm from conventional therapies to highly specific, molecular-level interventions. Next-Generation Nanomedicine lies at the forefront of this evolution, offering unprecedented control over biological interactions. This field focuses on the development of sophisticated nanomaterials and bio-inspired scaffolds designed to bridge the gap between traditional regenerative medicine and oncology.

For this Article Collection, we invite researchers and scientists to submit their original work that addresses the critical challenges in current medical practice. We are specifically seeking high-quality research and reviews that highlight:

• Innovative Biomaterial Design: Development of novel nanomaterials, scaffolds, or functionalized delivery systems that exhibit superior biocompatibility and therapeutic efficacy.
• Precision Targeting Mechanisms: Strategies for enhancing the selectivity of therapeutic payloads toward specific cell types, tissues, or organs, thereby minimizing systemic exposure.
• Synergistic Applications: Research that bridges regenerative medicine (promoting tissue repair) and oncology (eradicating malignant cells), demonstrating how these dual goals can be achieved via advanced materials.
• Clinical Translation Potential: Studies that offer insights into the stability, safety, and scalability of these nanotechnological solutions in complex biological environments.

By integrating functionalized nanomaterials, we aim to create systems that act with exquisite selectivity. This dual-focus approach promises to revolutionize how we repair damaged physiology while providing a robust framework for targeted cancer therapy. We look forward to your innovative submissions that push the boundaries of clinical precision and patient outcomes.

Current medical interventions often struggle with specificity. Traditional chemotherapy, for instance, acts as a "blunt instrument," damaging healthy cells alongside malignant ones, which leads to debilitating side effects. Similarly, regenerative medicine faces challenges in creating scaffolds that truly mimic the complex, dynamic microenvironments of human organs.

Establishing this Article Collection is of paramount importance because it directly addresses the critical bottleneck in modern medicine: the urgent need for therapeutic interventions that transcend the limitations of conventional, non-specific treatments. By creating a dedicated platform for the convergence of nanotechnology and materials science, we can accelerate the development of solutions that bridge the divide between regenerative medicine and oncology. Traditional medical approaches often rely on systemic delivery methods that cause extensive collateral damage to healthy tissue; this Article Collection will highlight the shift toward "smart," bio-functionalized materials capable of navigating complex biological environments with exquisite selectivity. Providing a centralized forum for this high-impact research not only fosters interdisciplinary collaboration but also serves to catalyze the transition from bench-top innovation to clinical reality, ultimately offering patients more effective, personalized, and safer treatment options that could redefine the prognosis for chronic diseases and cancer.

The International Journal of Nanomedicine is pleased to announce a dedicated Article Collection titled "Next-Generation Nanomedicine: From Tissue Engineering to Precision Cancer Treatment." This collection aims to provide a high-impact platform for researchers to present advancements in the development of sophisticated nanomaterials and bio-inspired scaffolds. By focusing on the intersection of regenerative medicine and oncology, this issue seeks to highlight platforms that offer molecular-level control, exceptional selectivity, and improved clinical efficacy.

Scope and Subtopics

To align with the rigorous standards of the International Journal of Nanomedicine, we invite submissions that bridge the gap between material design and biological application. We are particularly interested in, but not limited to, the following subtopics:

• Precision Targeted Delivery: Development of functionalized nanocarriers capable of site-specific payload release, utilizing stimuli-responsive mechanisms or ligand-mediated targeting to maximize impact on malignant cells while sparing healthy tissue.
• Advanced Scaffolds for Regeneration: Innovative use of bioactive nanomaterials in tissue engineering to create biomimetic microenvironments that stimulate natural repair processes and improve patient outcomes in degenerative conditions.
• Multifunctional Nanoplatforms: Design of "theranostic" systems that combine diagnostic imaging and therapeutic delivery to allow for real-time monitoring of tissue repair or cancer response.
• Biological Barrier Navigation: Strategies for enhancing the biodistribution and accumulation of nanomaterials within complex physiological targets, such as tumors or damaged organ systems.
• Safety and Translation: Investigations into the biocompatibility, pharmacokinetic profiles, and scalability of emerging nanomaterials intended for future clinical transition.

Preferred Article Types

To ensure a comprehensive overview of the field, we welcome the following contributions:

• Original Research Articles: Detailed accounts of novel experimental findings and technological breakthroughs.
• Comprehensive Reviews: Critical analyses of current progress, challenges, and future perspectives in nanotechnology for oncology or regenerative medicine.
• Short Communications: Brief reports on significant, timely developments or pilot studies.
• Perspective/Opinion Pieces: Thought-provoking discussions on the ethical, regulatory, or clinical hurdles facing the next generation of nanomedicine.

We encourage submissions that demonstrate rigorous characterization and clear clinical potential, contributing to the journal's mission of advancing nanomedicine from the bench to the bedside.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

Guest Advisors

Prof. Maciej Wnuk

Maciej Wnuk, Ph.D., D.Sc., is Professor at the University of Rzeszow (Poland), where he serves as a Group Leader in the Department of Biotechnology.He is co-author over 130 peer-reviewed international scientific publications and holds 8 patents. His research interests are centered on the molecular mechanisms of cellular senescence and cancer biology,  and developing innovative strategies that utilize nanoparticles as senolytic and anticancer agents.

Prof. Catarina Pinto Reis

Catarina Pinto Reis, Ph.D., is Assistant Professor with Habilitation at the Faculty of Pharmacy, University of Lisbon (FFUL), Portugal. She has co-authored over 160 peer-reviewed scientific publications and has extensive expertise in pharmaceutical technology, drug delivery systems, and nanomedicine. Her research focuses on the design and development of innovative nanocarriers and advanced biomaterials for targeted drug delivery, tissue regeneration, and precision therapeutics. Her work aims to bridge pharmaceutical sciences and translational medicine, contributing to the development of safer and more effective therapeutic strategies for a wide range of diseases.